Markets

Fauci: Coronavirus Vaccine Likely Not "Widely Available" Until Several Months Into 2021

Ever the voice of caution through the current pandemic, Dr. Anthony Fauci on Friday dampened enthusiasm that an effective and approved coronavirus vaccine is only months away.

Instead, he said during an interview with Washington Post journalist Bob Costa on Friday, "I think as we get into 2021, several months in, that you would have vaccine that would be widely available to people in the United States."

Anthony Fauci.

Image source: National Institute of Allergy and Infectious Diseases.

Certain companies, including ambitious biotech Moderna (NASDAQ: MRNA), are making good time putting their vaccine candidates through clinical trials. Yet Fauci, the high-profile director of the National Institute of Allergy and Infectious Diseases, doubts that even efforts such as Moderna's will yield a vaccine that will go into use by the end of 2020.

"I'm a little skeptical about that, but, you know, anything is possible," he said.

Fauci's skepticism is based on the processes vaccines have to undergo before coming to market, including comprehensive testing in phase 3 trials and regulatory review. Even when the latter is fast-tracked, it can still be a cumbersome process.

Another problem is production; no matter how prepared a manufacturer might be or how efficient its manufacturing partners, it takes time to produce millions of doses of any vaccine or medication -- particularly if it is new.

On Tuesday, executives from Moderna and peer healthcare companies AstraZeneca (NYSE: AZN), Johnson & Johnson (NYSE: JNJ), and Pfizer (NYSE: PFE) testified in a Congressional hearing about their efforts in developing coronavirus vaccines. They expressed optimism that their vaccines might be ready by the end of 2020 or very early next year.

10 stocks we like better than Moderna INC
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Moderna INC wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks

 

*Stock Advisor returns as of June 2, 2020

 

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends Johnson & Johnson. The Motley Fool has a disclosure policy.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MRNA PFE JNJ AZN

Latest Markets Videos

The Motley Fool

Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community. Reaching millions of people each month through its website, books, newspaper column, radio show, television appearances, and subscription newsletter services, The Motley Fool champions shareholder values and advocates tirelessly for the individual investor. The company's name was taken from Shakespeare, whose wise fools both instructed and amused, and could speak the truth to the king -- without getting their heads lopped off.

Learn More